Functional polymorphism rs189037 in the promoter region of ATM gene is associated with angiographically characterized coronary stenosis

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 694-697

  Li, Sheyu ^a   Zhang, Li ^a   Chen, Tie ^a   Tian, Baochun ^a   Deng, Xiangbing ^a   Zhao, Zhuoxian ^a   Yuan, Ping ^b   Dong, Birong ^a   Zhang, Yonggang ^a   Mo, Xianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Ataxia telangiectasia mutated (ATM); Coronary stenosis; Genetics; Single nucleotide polymorphism

Indexed keywords

ATM PROTEIN; MESSENGER RNA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANALYSIS OF VARIANCE; CELL CYCLE PROTEINS; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEINS;

EID: 82955168032     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.040     Document Type: Article

References (15)

1. Bonow R.O., Smaha L.A., Smith S.C., Mensah G.A., Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002, 106:1602-1605.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990. Nature 1993, 362:801-809.
3. Jackson S., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
4. Andreassi M.G. DNA damage, vascular senescence and atherosclerosis. J Mol Med 2008, 86:1033-1043.
5. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003, 3:155-168.
6. Su Y., Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 2000, 133:770-778.
7. Swift M., Chase C. Cancer and cardiac deaths in obligatory ataxia-telangiectasia heterozygotes. Lancet 1983, 1:1049-1050.
8. Wu D., Yang H., Xiang W., et al. Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 2005, 46:1380-1387.
9. Chen T., Dong B., Lu Z., et al. A functional single nucleotide polymorphism in promoter of ATM is associated with longevity. Mech Ageing Dev 2010, 131:636-640.
10. Scanlon P.J., Faxon D.P., Audet A.M., et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 1999, 99:2345-2357.
11. Drexel H., Amann F.W., Beran J., et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994, 90:2230-2235.
12. Muendlein A., Saely C.H., Rhomberg S., et al. Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease. Atherosclerosis 2009, 205:174-180.
13. Matthews C., Gorenne I., Scott S., et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res 2006, 99:156-164.
14. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198:347-353.
15. Andreassi M.G. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009, 667:35-43.